Profound Medical Corp. (PROF)
USD 5.0
(-6.98%)
USD 5.0
(-6.98%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 7.33 Million USD | 9.73% |
| 2022 | 6.68 Million USD | -2.79% |
| 2021 | 6.87 Million USD | -5.9% |
| 2020 | 7.3 Million USD | 72.61% |
| 2019 | 4.23 Million CAD | 121.48% |
| 2018 | 1.91 Million CAD | -51.01% |
| 2017 | 3.9 Million CAD | 0.0% |
| 2016 | - CAD | 0.0% |
| 2015 | - CAD | 0.0% |
| 2014 | - CAD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 2.23 Million USD | 16.91% |
| 2024 Q1 | 1.9 Million USD | -4.93% |
| 2023 Q1 | 1.86 Million USD | 47.97% |
| 2023 FY | 7.33 Million USD | 9.73% |
| 2023 Q4 | 2.06 Million USD | 19.47% |
| 2023 Q3 | 1.72 Million USD | 7.87% |
| 2023 Q2 | 1.6 Million USD | -13.87% |
| 2022 Q1 | 1.36 Million USD | 36.67% |
| 2022 Q3 | 2.03 Million USD | 0.49% |
| 2022 Q4 | 1.25 Million USD | -38.23% |
| 2022 Q2 | 2.02 Million USD | 48.46% |
| 2022 FY | 6.68 Million USD | -2.79% |
| 2021 FY | 6.87 Million USD | -5.9% |
| 2021 Q1 | 711 Thousand USD | -75.05% |
| 2021 Q3 | 2.53 Million USD | -3.43% |
| 2021 Q4 | 998 Thousand USD | -60.66% |
| 2021 Q2 | 2.62 Million USD | 269.48% |
| 2020 Q1 | 1.1 Million CAD | -49.25% |
| 2020 Q3 | 2.22 Million CAD | 114.0% |
| 2020 Q4 | 2.84 Million USD | 27.98% |
| 2020 FY | 7.3 Million USD | 72.61% |
| 2020 Q2 | 1.04 Million CAD | -5.41% |
| 2019 Q1 | 1.1 Million CAD | -9.34% |
| 2019 Q4 | 2.16 Million CAD | 320.63% |
| 2019 Q3 | 515.35 Thousand CAD | 17.84% |
| 2019 Q2 | 437.31 Thousand CAD | -60.43% |
| 2019 FY | 4.23 Million CAD | 121.48% |
| 2018 Q3 | 235.03 Thousand CAD | 44.89% |
| 2018 Q1 | 291.41 Thousand CAD | -80.18% |
| 2018 FY | 1.91 Million CAD | -51.01% |
| 2018 Q4 | 1.21 Million CAD | 418.72% |
| 2018 Q2 | 162.21 Thousand CAD | -44.34% |
| 2017 Q3 | 1.18 Million CAD | 60.51% |
| 2017 FY | 3.9 Million CAD | 0.0% |
| 2017 Q4 | 1.47 Million CAD | 24.49% |
| 2017 Q2 | 735.94 Thousand CAD | 65.92% |
| 2017 Q1 | 443.55 Thousand CAD | 0.0% |
| 2016 Q1 | - CAD | 0.0% |
| 2016 Q3 | - CAD | 0.0% |
| 2016 Q4 | - CAD | 0.0% |
| 2016 FY | - CAD | 0.0% |
| 2016 Q2 | - CAD | 0.0% |
| 2015 Q2 | - CAD | 0.0% |
| 2015 Q1 | - CAD | 0.0% |
| 2015 Q4 | - CAD | 0.0% |
| 2015 FY | - CAD | 0.0% |
| 2015 Q3 | - CAD | 0.0% |
| 2014 Q1 | - CAD | 0.0% |
| 2014 Q4 | - CAD | 0.0% |
| 2014 FY | - CAD | 0.0% |
| 2014 Q3 | - CAD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 12.05 Million USD | 39.207% |
| BrainsWay Ltd. | 31.78 Million USD | 76.936% |
| Cerus Corporation | 156.36 Million USD | 95.312% |
| Envoy Medical, Inc. | 316 Thousand USD | -2219.943% |
| electroCore, Inc. | 16.03 Million USD | 54.267% |
| Helius Medical Technologies, Inc. | 644 Thousand USD | -1038.357% |
| IceCure Medical Ltd | 3.22 Million USD | -127.037% |
| Inogen, Inc. | 315.66 Million USD | 97.678% |
| OrthoPediatrics Corp. | 148.73 Million USD | 95.071% |
| Lucid Diagnostics Inc. | 2.42 Million USD | -201.937% |
| Monogram Orthopaedics, Inc. | 364.99 Thousand USD | -1908.504% |
| MaxCyte, Inc. | 41.28 Million USD | 82.244% |
| NeuroOne Medical Technologies Corporation | 1.95 Million USD | -275.48% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -6519.552% |
| Orthofix Medical Inc. | 746.64 Million USD | 99.018% |
| PAVmed Inc | 2.45 Million USD | -198.981% |
| Rapid Micro Biosystems, Inc. | 22.51 Million USD | 67.445% |
| RxSight, Inc. | 89.07 Million USD | 91.77% |
| Sight Sciences, Inc. | 81.05 Million USD | 90.956% |
| SI-BONE, Inc. | 138.88 Million USD | 94.722% |
| TELA Bio, Inc. | 58.45 Million USD | 87.458% |
| Treace Medical Concepts, Inc. | 187.11 Million USD | 96.082% |
| Vivos Therapeutics, Inc. | 13.8 Million USD | 46.881% |
| Acutus Medical, Inc. | 7.16 Million USD | -2.331% |
| Talis Biomedical Corporation | 412 Thousand USD | -1679.374% |
| Spectral AI, Inc. | 18.05 Million USD | 59.398% |
| Nano-X Imaging Ltd. | 9.9 Million USD | 25.987% |
| CVRx, Inc. | 39.29 Million USD | 81.344% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 968.7 Thousand USD | -656.785% |
| Bioventus Inc. | 512.34 Million USD | 98.569% |
| Venus Concept Inc. | 76.35 Million USD | 90.399% |
| TriSalus Life Sciences, Inc. | 18.51 Million USD | 60.396% |
| LivaNova PLC | 1.15 Billion USD | 99.364% |
| 908 Devices Inc. | 50.22 Million USD | 85.405% |
| Alphatec Holdings, Inc. | 482.26 Million USD | 98.48% |
| Nemaura Medical Inc. | 77.04 Thousand USD | -9415.369% |
| NeuroPace, Inc. | 65.42 Million USD | 88.794% |
| LENSAR, Inc. | 42.16 Million USD | 82.613% |
| Apyx Medical Corporation | 52.34 Million USD | 85.996% |
| Cutera, Inc. | 212.36 Million USD | 96.548% |
| STRATA Skin Sciences, Inc. | 33.35 Million USD | 78.023% |
| BioSig Technologies, Inc. | 18 Thousand USD | -40627.894% |
| Anika Therapeutics, Inc. | 166.66 Million USD | 95.601% |
| ClearPoint Neuro, Inc. | 23.95 Million USD | 69.397% |
| Integra LifeSciences Holdings Corporation | 1.54 Billion USD | 99.524% |
| Axonics, Inc. | 366.37 Million USD | 97.999% |
| Outset Medical, Inc. | 130.37 Million USD | 94.377% |
| IRIDEX Corporation | 51.86 Million USD | 85.866% |
| PROCEPT BioRobotics Corporation | 136.19 Million USD | 94.617% |
| IRadimed Corporation | 65.56 Million USD | 88.818% |
| Tivic Health Systems, Inc. | 1.17 Million USD | -523.386% |
| INVO Bioscience, Inc. | 3.02 Million USD | -142.703% |
| Telesis Bio, Inc. | 27.5 Million USD | 73.35% |
| Viemed Healthcare, Inc. | 183 Million USD | 95.994% |
| Varex Imaging Corporation | 811 Million USD | 99.096% |
| Quipt Home Medical Corp. | 221.74 Million USD | 96.694% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 68.67 Million USD | 89.325% |
| Dynatronics Corporation | 32.53 Million USD | 77.467% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 8.67 Million USD | 15.522% |
| Semler Scientific, Inc. | 68.18 Million USD | 89.248% |
| InMode Ltd. | 492.04 Million USD | 98.51% |
| Bruker Corporation | 2.96 Billion USD | 99.753% |
| Cytosorbents Corporation | 36.34 Million USD | 79.832% |
| DexCom, Inc. | 3.62 Billion USD | 99.798% |
| Align Technology, Inc. | 3.86 Billion USD | 99.81% |
| Viveve Medical, Inc. | 6.42 Million USD | -14.084% |
| ZimVie Inc. | 457.43 Million USD | 98.397% |
| Movano Inc. | - USD | -Infinity% |
| Cytek Biosciences, Inc. | 193.01 Million USD | 96.202% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -6519.552% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 747.71 Million USD | 99.02% |
| Insulet Corporation | 1.69 Billion USD | 99.568% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 126.07 Million USD | 94.185% |
| iCAD, Inc. | 17.31 Million USD | 57.668% |
| Nuwellis, Inc. | 8.86 Million USD | 17.294% |
| Biotricity, Inc. | 12.06 Million USD | 39.229% |
| iRhythm Technologies, Inc. | 492.68 Million USD | 98.512% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 6.2 Million USD | -18.147% |
| PAVmed Inc. | 2.45 Million USD | -198.981% |
| BIOLASE, Inc. | 49.16 Million USD | 85.089% |
| Beyond Air, Inc. | 1.15 Million USD | -532.53% |
| FONAR Corporation | 102.88 Million USD | 92.874% |
| AxoGen, Inc. | 159.01 Million USD | 95.39% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 274.42 Million USD | 97.329% |
| Inari Medical, Inc. | 493.63 Million USD | 98.515% |
| UFP Technologies, Inc. | 400.07 Million USD | 98.168% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 18.6 Thousand USD | -39314.091% |
| Tenon Medical, Inc. | 2.92 Million USD | -150.376% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 6.81 Million USD | -7.619% |
| AdaptHealth Corp. | 3.2 Billion USD | 99.771% |
| Sintx Technologies, Inc. | 2.62 Million USD | -179.064% |
| NanoVibronix, Inc. | 2.28 Million USD | -221.113% |
| Quanterix Corporation | 122.36 Million USD | 94.009% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 24.4 Million USD | 69.961% |
| Pacific Biosciences of California, Inc. | 200.52 Million USD | 96.344% |
| TransMedics Group, Inc. | 241.62 Million USD | 96.966% |
| ReWalk Robotics Ltd. | 13.85 Million USD | 47.084% |
| NeuroMetrix, Inc. | 5.9 Million USD | -24.225% |
| Hyperfine, Inc. | 11.03 Million USD | 33.548% |
| Establishment Labs Holdings Inc. | 165.15 Million USD | 95.561% |
| Biomerica, Inc. | 5.41 Million USD | -35.384% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 50.56 Million USD | 85.501% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 177.13 Million USD | 95.861% |